KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Raw Materials (2016 - 2025)

Stereotaxis (STXS) has disclosed Raw Materials for 15 consecutive years, with $6.5 million as the latest value for Q4 2025.

  • Quarterly Raw Materials rose 24.74% to $6.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.5 million through Dec 2025, up 24.74% year-over-year, with the annual reading at $6.5 million for FY2025, 24.74% up from the prior year.
  • Raw Materials for Q4 2025 was $6.5 million at Stereotaxis, down from $6.7 million in the prior quarter.
  • The five-year high for Raw Materials was $7.8 million in Q1 2023, with the low at $2.9 million in Q1 2021.
  • Average Raw Materials over 5 years is $5.7 million, with a median of $6.0 million recorded in 2024.
  • The sharpest move saw Raw Materials crashed 33.49% in 2021, then surged 109.2% in 2022.
  • Over 5 years, Raw Materials stood at $3.6 million in 2021, then surged by 80.01% to $6.6 million in 2022, then fell by 9.73% to $5.9 million in 2023, then dropped by 11.74% to $5.2 million in 2024, then rose by 24.74% to $6.5 million in 2025.
  • According to Business Quant data, Raw Materials over the past three periods came in at $6.5 million, $6.7 million, and $6.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.